LOX and atrial fibrillation: The mechanism underlying these effects was deciphered using pharmacological and gene knockdown strategies in both cardiac fibroblasts and transgenic mice with cardiac overexpression of constitutively active Rac1 (RacET), which develop atrial fibrosis and spontaneous AF with aging, characterized by increased LOX expression, collagen content, and cross-linking.